Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-051370

Chairman and CEO bought 300 shares at $1.30 ($390)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-09-17 Purchase +300 $1.30 $390 10,684,746 D
Open-market purchases · 300 sh · avg $1.30 · $390
Loading xslF345X03/doc4.xml…